focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,364.00
Bid: 12,398.00
Ask: 12,400.00
Change: 268.00 (2.22%)
Spread: 2.00 (0.016%)
Open: 12,150.00
High: 12,440.00
Low: 12,134.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks end shortened week on positive note

Thu, 06th Apr 2023 17:03

(Alliance News) - Stocks in London closed higher on Thursday, ahead of the long Easter weekend, defying gloomy local data as well as increasing expectations of a global economic slowdown.

The FTSE 100 index closed up 78.62 points, or 1.0% at 7,741.56 on Thursday. The FTSE 250 ended up 195.61 points, or 1.1%, at 18,797.03. The AIM All-Share closed up 7.51 points, or 0.9%, at 811.20.

The Cboe UK 100 ended up 1.1% at 774.27, the Cboe UK 250 closed up 1.5% at 16,382.65, and the Cboe Small Companies ended up 1.2% at 13,505.45.

UK house prices saw their weakest annual growth since late 2019, data from Halifax revealed.

According to the mortgage lender, average house prices edged up 0.8% in March on a monthly basis. Growth slowed from a 1.2% climb in February.

Annually, growth in house prices slowed to 1.6% in March, from the 2.1% climb seen in each of the previous three months. It was the weakest rate of growth since October 2019, Halifax noted.

In addition to this, growth in the UK construction sector slowed faster than expected last month, led by falling housing activity.

The S&P Global/CIPS UK construction purchasing managers' index fell to 50.7 points in March from 54.6 in February.

The slowdown was faster than the market had expected, with FXStreet-cited consensus anticipating a reading of 53.5.

As a result, sterling suffered. The pound was quoted at USD1.2436 at the London equities close on Thursday, down from USD1.2471 at the close on Wednesday.

Adding to Thursday's gloomy economic picture was the International Monetary Fund's managing director who warned that a continued slowdown in almost all the world's advanced economies is expected to drag global growth below 3% this year.

"With rising geopolitical tensions and still-high inflation, a robust recovery remains elusive," Kristalina Georgieva said in prepared remarks ahead of the IMF and World Bank's spring meetings next week.

She added that world growth will likely remain at roughly three percent for the next half-decade, the lowest medium-term forecast since the 1990s.

In the FTSE 100, Shell rose 2.3% after it said it expects a rise in Integrated Gas production in the first quarter of 2023.

However, the oil major also predicted an adjusted loss in its corporate segment between USD900 million and USD1.2 billion, widening from USD600 million in the fourth quarter of 2022. The outcome "includes one-off tax charges", the company said.

Oil company profits have come under tax scrutiny recently. Energy firms have benefitted from robust oil prices, a stark contrast to a cost of living crisis consumers are suffering from.

For Integrated Gas, Shell forecast production between 930,000 to 970,000 barrels of oil equivalent, up from 917,000 boe in the fourth quarter.

AstraZeneca climbed 0.8% after the NHS approved the use of its drug Olaparib, also known as Lynparza, for patients with breast cancer and prostate cancer.

The drug targets cancers with BRCA 1 or BRCA 2 mutations and works by stopping cancer cells from being able to repair their DNA, which causes the cancerous cells to die.

In the FTSE 250, Tui jumped 12% as it reported that booking momentum remained encouraging ahead of the Easter holding.

The holiday operator said bookings and trends for Easter holidays confirmed strong demand across all markets for destinations such as the Canary Islands, Turkey, the Balearics, mainland Spain, Egypt and Greece.

It expects over 500,000 customers on holiday with Tui over Easter, with a load factor in the range of 95%, which it said was broadly in line pre-pandemic levels.

Ferrexpo added 5.4% as it announced that iron ore pellet production doubled quarter-on-quarter in the first three months of 2023, as it saw a more steady supply of electricity during the period.

The firm, with operations in central Ukraine, reported that production for the first quarter ended March 31 was 901,000 tonnes, compared with 420,000 million tonnes in the fourth quarter of 2022.

Elsewhere in London, Robert Walters fell 2.5% as the company reported a "slower" start to the year amid continued economic uncertainty.

The recruitment company said net fee income in the first quarter of 2023 was GBP102.4 million, up 4.1% from GBP98.4 million the year prior.

Liberum analyst Sanjay Vidyarthi said that the first quarter slowdown was "as expected", warning that the first half of the year will "likely to be difficult" for the firm.

In European equities on Thursday, the CAC 40 in Paris ended up 0.1%, while the DAX 40 in Frankfurt ended 0.5% higher.

The euro stood at USD1.0919 at the European equities close on Thursday, unchanged from USD1.0919 at the same time on Wednesday.

Against the yen, the dollar was trading at JPY131.72, higher compared to JPY130.94 late Wednesday.

Stocks in New York were in the red at the London equities close, with the Dow Jones Industrial Average down 0.3%, the S&P 500 index down 0.2%, and the Nasdaq Composite trading marginally lower.

US initial claims for unemployment support topped expectations last week, in a further sign that the once red-hot labour market is weakening.

According to the Department of Labor, initial jobless claims amounted to 228,000 for the week ended April 1, down 18,000 from a week earlier. The previous week's reading was upwardly revised to 246,000 from 198,000.

The latest figure came in above expectations of 200,000.

The labour market data comes ahead of a "pivotal" nonfarm payrolls reading, released on Friday at 1330 BST.

Axel Rudolph, senior market analyst at IG, said: "Friday's US payrolls report will be a pivotal one for stocks. The worst outcome would be rising wages and a weaker jobs number, something that might reverse the growing expectation of a Fed pause in May. Such a scenario would likely put stocks at risk of giving back their recent gains."

Brent oil was quoted at USD84.88 a barrel at the London equities close on Thursday, up from USD84.48 late Wednesday. Gold was quoted at USD2,009.21 an ounce, lower against USD2,021.30.

"The outlook for gold is closely tied to that of US yields which have fallen considerably in the aftermath of the banking turmoil and are falling once more as recession fears resurface. That's helped propel gold above USD2,000, a level above which it has only ever spent a handful of days," said Craig Erlam, senior market analyst at Oanda.

Financial markets in London, New York and across Europe and will be closed tomorrow for Good Friday. In Friday's economic calendar, the latest US nonfarm payrolls reading is reported at 1330 BST.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.